v3.26.1
SEGMENT INFORMATION - Schedule of Reportable Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue from External Customer [Line Items]    
Total revenues $ 766,208 $ 745,145
Cost of sales 194,999 151,558
R&D expenses 178,796 158,731
NET INCOME 105,527 185,686
Reportable Segment    
Revenue from External Customer [Line Items]    
Total revenues 766,208 745,145
Cost of sales 194,999 151,558
S&M expenses 124,927 102,531
G&A expenses 133,363 103,585
Other segment expense, net 28,596 43,054
NET INCOME 105,527 185,686
Research and early pipeline | Reportable Segment    
Revenue from External Customer [Line Items]    
R&D expenses 87,291 90,470
Later-stage clinical programs | Reportable Segment    
Revenue from External Customer [Line Items]    
R&D expenses 36,177 14,291
Marketed products | Reportable Segment    
Revenue from External Customer [Line Items]    
R&D expenses $ 55,328 $ 53,970